Nav: Home

$2.5 million boost for lymphoma research through Tanoto Foundation

May 18, 2016

Professorship will focus on research to improve diagnostic and clinical outcomes for Non-Hodgkin's Lymphoma

Singapore, May 18, 2016 - The SingHealth Duke-NUS Academic Medical Centre announced today that a S$2.5 million Tanoto Foundation Professorship in Medical Oncology has been conferred to Assoc Prof Lim Soon Thye, Head and Senior Consultant of the Division of Medical Oncology at the National Cancer Centre Singapore; and Assistant Dean at Duke-NUS Medical School.

The Professorship recognises Assoc Prof Lim as an outstanding clinician and researcher who has demonstrated academic leadership with his pioneering work on the genetic basis of cancers that are prevalent in Asia. The funding aims to advance Assoc Prof Lim's research on Non-Hodgkin's Lymphoma, a cancer prevalent in Asia that ranks among the top 10 cancers in Singapore.

Assoc Prof Lim's research focuses on lymphoid malignancies, and particularly on T and NK/T cell lymphomas that occur more frequently among Asians. There is currently no standard accepted treatment for these lymphomas, and even with conventional chemotherapy, less than 50 per cent of these patients can be cured.

He is co-founder of the Asian Lymphoma Study Group, which brings together researchers across Asia to collaborate on Asian-related lymphoma studies. He is also founder of the Singapore Lymphoma Study Group that galvanises Singapore researchers in basic and translational research for lymphoma. To date, the group has set up a clinical and pathological database of more than 3,000 patients in Singapore and a tissue bank encompassing more than 1,000 blood and close to 500 frozen tissue specimens. Together, these resources have boosted researchers' ability to examine the lymphoma's molecular manner of development.

Professor Soo Khee Chee, Deputy CEO (Research & Education), SingHealth and Senior Vice Dean, Clinical, Academic & Faculty Affairs, Duke-NUS Medical School shares, "The incidence of Non-Hodgkin's Lymphoma has increased dramatically worldwide, especially in Asia, but diagnostic and treatment outcomes remain poor. This Professorship will advance the search for novel diagnostic strategies, drugs and treatments that can improve survival for lymphoma patients."

Over the years, Assoc Prof Lim's research has gained much traction, with work published in major international journals. He is currently the lead investigator of the National Lymphoma Translational Research Programme that is funded by the National Medical Research Council. He is also one of the principal investigators of the blood cancer (T cell lymphoma) genomics project at the International Cancer Genomics Consortium, a voluntary scientific organisation that provides a forum for collaboration among the world's leading cancer and genomic researchers.

The Tanoto Foundation Professorship in Medical Oncology is part of a $3 million gift from the Tanoto Foundation. The remaining sum will be used to set up the Tanoto Foundation Initiative in Asian Lymphoma Research.The gift was matched dollar-for-dollar by the Singapore Government.

Mr Sukanto Tanoto, Founder of Tanoto Foundation and Chairman of its Board of Trustees, said, "The Foundation is pleased to support innovative work to find remedies for heart diseases and cancer which are leading causes of adult mortality. We are hopeful that Asia-focussed lymphoma research will promote breakthroughs in diagnosis and treatment, thereby improving the quality of life for patients and their families."
-end-
Media contact:

Anjana Krishna
SingHealth Group Communications
Tel: 65-6377-8056
Email: anjana.krishna.kumar@singhealth.com.sg

About Singapore Health Services (SingHealth)

The SingHealth Duke-NUS Academic Medical Centre draws on the collective strengths of SingHealth and Duke-NUS Medical School to drive the transformation of healthcare and provide affordable, accessible, quality healthcare. With 42 clinical specialties, a network of 2 Hospitals, 5 National Specialty Centres, 9 Polyclinics and Bright Vision Community Hospital, it delivers comprehensive, multi-disciplinary and integrated care. In 2018, the Sengkang General Hospital and Sengkang Community Hospital will be completed to serve the community in the north-east of Singapore. To enhance community care, the new Outram Community Hospital on SGH Campus will be completed in 2020.

For more information, please visit: http://www.singhealth.com.sg

Members of the SingHealth group

Hospitals (Tertiary Specialty Care):

Singapore General Hospital, KK Women's and Children's Hospital, Sengkang General Hospital (expected completion: 2018)

National Specialty Centres (Tertiary Specialty Care):

National Cancer Centre Singapore, National Dental Centre Singapore, National Heart Centre Singapore, National Neuroscience Institute, and Singapore National Eye Centre

SingHealth Polyclinics (Primary Care):

Bedok, Bukit Merah, Geylang, Marine Parade, Outram, Pasir Ris, Queenstown, Sengkang, and Tampines

Community Hospitals (Intermediate and Long-term Care):

Bright Vision Hospital, Sengkang Community Hospital (expected completion: 2018), Outram Community Hospital (expected completion: 2020)

About Duke-NUS Medical School

The Duke-NUS Medical School (Duke-NUS) was established in 2005 as a strategic collaboration between the Duke University School of Medicine, located in North Carolina, USA, and the National University of Singapore (NUS). Duke-NUS offers a graduate-entry, 4-year MD (Doctor of Medicine) training programme based on the unique Duke model of education, with one year dedicated to independent study and research projects of a basic science or clinical nature. Duke-NUS also offers MD/PhD and PhD programmes. Duke-NUS has five Signature Research Programmes: Cancer and Stem Cell Biology, Neuroscience and Behavioural Disorders, Emerging Infectious Diseases, Cardiovascular and Metabolic Disorders, and Health Services and Systems Research.

Duke-NUS and SingHealth have established a strategic partnership in academic medicine that will guide and promote the future of medicine, tapping on and combining the collective strengths of SingHealth's clinical expertise and Duke-NUS' biomedical sciences research and medical education capabilities.

For more information, please visit http://www.duke-nus.edu.sg

About Tanoto Foundation Professorship
  • Tanoto Foundation Professorship in Cardiovascular Medicine
  • Tanoto Foundation Professorship in Medical Oncology
  • Tanoto Foundation Professorship in Diabetes Research


In 2009, Tanoto Foundation made its first donation of S$5 million to Duke-NUS to establish a Professorship and Research Initiative in Diabetes. Following this, Tanoto Foundation contributed another S$3 million each, to support the Professorship in Medical Oncology and Research Initiative in Asian Lymphoma, as well as the Professorship in Cardiovascular Medicine and Research Initiative in Genetics & Stem Cell, bringing a total of S$11 million in donations.

These donations have enabled the advancement of research and medicine in Asia to identify new ways of diagnosing patients with high accuracy, thereby allowing early prevention and better treatments.

About Tanoto Foundation

Founded by Sukanto Tanoto and his wife Tinah Bingei Tanoto, Tanoto Foundation strives to be a centre of excellence in poverty alleviation through education, empowerment, and enhancement of quality of lives. Tanoto Foundation's mission is to work with communities and partners to address root causes of poverty in countries where the Tanoto family has significant presence.

To date, Tanoto Foundation has provided over 20,000 scholarships, built several schools and education facilities that produced 27,000 graduates, developed 60,000 hectares of Community Livelihood Plantations and created more than 1,800 jobs in local communities through Small to Medium size Enterprise (SME) programmes. As an accomplished self-made entrepreneur, visionary and pioneer of a number of industries in Indonesia, Mr Sukanto's success in growing his business empire is widely recognised. Despite having to leave school at the age of 17 to support his family, his relentless hunger for knowledge drives him to continue learning through various means, including taking up courses in renowned universities around the world till today.

In 2012, he was awarded the Wharton School Dean's Medal Award -- which recognizes individuals for their contributions to the enlargement of the global economy and to the improvement of lives worldwide.

SingHealth

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.